Croissance Ltd Q3 FY26: Revenue Nil, Income ₹20.27cr

Results season backdrop: board meetings line up

Indian listed companies typically cluster board meetings around April and May to approve audited annual results, consider dividends, and clear other statutory matters. Exchange filings over the period show multiple companies scheduling meetings for financial results, including several large caps alongside smaller firms. Against that backdrop, Croissance Ltd has also made disclosures around its quarterly approvals and board meeting agenda for the December 2025 quarter. These filings matter because they set the timing for audited and unaudited disclosures and, in some cases, dividends.

What Croissance Ltd disclosed for the December 2025 quarter

Croissance Ltd (BSE code: 531909; ISIN: INE587J01027) announced unaudited financial results for the quarter and nine months ended December 31, 2025. The company said the Board of Directors approved these results in a meeting held on January 6, 2026. The financial results were prepared in accordance with Indian Accounting Standard (Ind AS) and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also stated that there are no reportable segments as per the provisions of the relevant Ind AS.

The disclosure also noted that the company’s profit before tax for the quarter increased by a certain percentage compared to the same period last year, without specifying the percentage in the provided text. As a result, only the direction of change can be reported from the available information.

Key Q3 FY26 numbers: operations revenue at nil

For the quarter ended December 31, 2025, Croissance reported that standalone total revenue from operations was nil. At the same time, standalone other income stood at ₹20.27 crore (₹2027 lakh). This distinction is important because it separates operating activity from other income, and it frames how the quarter’s reported income mix was structured.

The company’s filings referenced both standalone and consolidated unaudited results being approved for the quarter ended December 31, 2025. However, beyond the statement about nil standalone revenue from operations and the standalone other income figure, additional line items were not provided in the input text.

Board meeting details and agenda

Croissance said a board meeting was scheduled for January 6, 2026, at 4:00 PM at its registered office. The agenda included the consideration of un-audited financial results for the quarter ended December 31, 2025. The company also referred to a trading window closure for designated persons, but the end date and detailed mechanics were not fully available in the provided content.

Separately, the dataset also contains references to other historical board meeting dates for Croissance across multiple years for quarterly results and audited results. These dates help investors track the company’s reporting cadence, but they do not, by themselves, provide additional financial outcomes.

Stock snapshot provided with the disclosure

The provided text includes a market snapshot for Croissance around the disclosure:

• Latest trading price: ₹3.67
• Change: ₹0.05 (1.38%)
• Book value: ₹1.15
• Face value: ₹1
• Dividend and yield: 0
• Market capitalisation: ₹25.98 crore

These figures give a basic picture of the stock’s trading context, but they are not a substitute for the company’s full financial statements.

FY2023-24 context from the directors’ report

The input also contains figures from the company’s directors’ report for the financial year ended March 31, 2024. On a standalone basis, Croissance reported total revenue of ₹0.663 crore (₹66.30 lakh) for FY2023-24, compared with ₹2.6033 crore (₹260.33 lakh) in the previous financial year. The company reported net profit of ₹0.0684 crore (₹6.84 lakh) for FY2023-24 versus ₹0.4894 crore (₹48.94 lakh) in the previous year.

It also reported earnings per equity share (basic and diluted) of ₹0.01 for FY2023-24 compared with ₹0.07 in the previous year. The directors’ report stated that the statutory auditor’s report for the year ended March 31, 2024 did not have any reservation, qualification, or adverse remarks, based on the text provided.

Compliance note mentioned in the report

One specific compliance item included in the text relates to Section 137(1). The disclosure stated that the company had not filed a copy of financial statements with required documents with the Registrar within thirty days of the AGM date in Form AOC-4 XBRL for the financial year ended 31.03.2023. The text added that management assured corrective action had been initiated to avoid such instances in future.

Wider calendar: other companies’ board meeting intimations

Alongside Croissance, the input lists board meeting intimations for multiple companies for financial results and dividends. Only entries with clear dates in the provided text are summarised below.

Table: Croissance numbers explicitly available

Only the metrics explicitly present in the provided text are included.

Why these disclosures matter for investors

For Croissance, the combination of nil revenue from operations and a large other income figure in the quarter draws attention to the composition of reported income. Investors typically look to operating revenue as a signal of core business activity, while other income can be driven by non-operating sources. The company’s statement that there are no reportable segments also indicates the absence of segment-level breakups in its Ind AS reporting.

For the broader market, the April-May board meeting calendar is important because audited annual results and dividend decisions are frequently cleared in these meetings. The provided list shows several companies explicitly combining results approvals with dividend consideration, reinforcing how closely these agenda items are linked in reporting season.

Conclusion

Croissance Ltd’s Q3 FY26 filing highlighted nil standalone revenue from operations and ₹20.27 crore of standalone other income for the quarter ended December 31, 2025, with the results approved by the board on January 6, 2026. In parallel, multiple companies have scheduled board meetings across April and May 2026 to approve audited results and consider dividends, underscoring the peak reporting period on Indian exchanges. The next concrete updates will come from subsequent board outcomes and detailed financial statements as and when disclosed through exchange filings.